TISSUE REPAIR LTD - Announcements

0.00%

27.5¢

Market Cap $16.62M

Healthcare Biotechnology

Tissue Repair Limited is an Australia-based Phase III advanced biotechnology company... Tissue Repair Limited is an Australia-based Phase III advanced biotechnology company developing second generation wound healing agents. The Company is focused in entering Phase III clinical trials in chronic wounds for its lead drug candidate Chronic wound treatment (TR-987), with a secondary focus on commercializing Post-procedure cosmeceutical (TR Pro+) a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its other applications of Glucoprime technology include the treatment of burns, an over the counter/pharmacy wound product, new bandage and scaffold products impregnated with Tissue Repair’s active pharmaceutical ingredient, veterinary products, among others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

TRP	Appendix 4E and Annual Report 30 June 2025	PRICE SENSITIVE	29/08/25	1.09MB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/25	348.36KB	Share
TRP	Major Distribution Agreement secured for TR Pro	PRICE SENSITIVE	11/07/25	163.83KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	1.3MB	Share
TRP	Appendix 4D and Half Year Report to 31 December 2024	PRICE SENSITIVE	27/02/25	415.74KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	414.89KB	Share
TRP	Phase 3 Clinical Trial Programme for TR987	PRICE SENSITIVE	29/01/25	599.56KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	18/10/24	1.52MB	Share
TRP	Takeover Panel Media release & Independent Director changes	PRICE SENSITIVE	25/09/24	121.55KB	Share
TRP	TOV: TRP - Panel Accepts Undertaking and Declines to Conduct	PRICE SENSITIVE	20/09/24	266.46KB	Share
TRP	TOV: TRP - Panel Receives Application	PRICE SENSITIVE	29/08/24	186.01KB	Share
TRP	Appendix 4E and Annual Report 30 June 2024	PRICE SENSITIVE	22/08/24	1.06MB	Share
TRP	Tony Charara Co-founder appointed as CEO	PRICE SENSITIVE	08/08/24	130.26KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	1008.67KB	Share
TRP	TGA approval granted for Tissue Repair TR Pro	PRICE SENSITIVE	25/07/24	155.42KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	439.31KB	Share
TRP	Appendix 4D and Half Year Report to 31 December 2023	PRICE SENSITIVE	29/02/24	530.95KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/24	433.41KB	Share
TRP	Third US Patent granted for Tissue Repair Glucoprime	PRICE SENSITIVE	19/12/23	190.65KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/23	518.18KB	Share
TRP	Appendix 4E and Annual Report 30 June 2023	PRICE SENSITIVE	31/08/23	1.26MB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	482.99KB	Share
TRP	FDA clears TR-987 to progress to Phase 3	PRICE SENSITIVE	29/05/23	178KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	401.11KB	Share
TRP	Bank Deposits At SVB Available Tuesday 14 March 2023 AEDT	PRICE SENSITIVE	13/03/23	134.31KB	Share
TRP	Update on Cash Held with Silicon Valley Bank	PRICE SENSITIVE	13/03/23	178.72KB	Share
TRP	Appendix 4D and Half Year Report to 31 December 2022	PRICE SENSITIVE	22/02/23	888.67KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/23	362.94KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	347.29KB	Share
TRP	TR Pro accepted for peer reviewed journal publication	PRICE SENSITIVE	12/10/22	213.25KB	Share
TRP	FDA Response Clarifies Path to Phase 3 Trials	PRICE SENSITIVE	28/09/22	207.95KB	Share
TRP	Second US Patent granted for Glucoprime	PRICE SENSITIVE	05/09/22	152.96KB	Share
TRP	Appendix 4E and Annual Report 30 June 2022	PRICE SENSITIVE	31/08/22	1.63MB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	271.34KB	Share
TRP	Lodgement of Type C Meeting Request with US FDA	PRICE SENSITIVE	01/07/22	166.23KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	281.8KB	Share
TRP	Tissue Repair Announces USA Patent Approval	PRICE SENSITIVE	04/03/22	128.94KB	Share
TRP	Appendix 4D and Half Year Report to 31 December 2021	PRICE SENSITIVE	25/02/22	613.7KB	Share
TRP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	427.58KB	Share
TRP	Tissue Repair Progresses TR-987 towards Phase III	PRICE SENSITIVE	23/11/21	131.76KB	Share
TRP	Suspension from Official Quotation	PRICE SENSITIVE	28/09/18	70.08KB	Share
TRP	Admission to Official List	PRICE SENSITIVE	10/05/10	24.28KB	Share

TRP Appendix 4E and Annual Report 30 June 2025
29/08/25	PRICE SENSITIVE	1.09MB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
31/07/25	PRICE SENSITIVE	348.36KB	Share
TRP Major Distribution Agreement secured for TR Pro
11/07/25	PRICE SENSITIVE	163.83KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	1.3MB	Share
TRP Appendix 4D and Half Year Report to 31 December 2024
27/02/25	PRICE SENSITIVE	415.74KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	414.89KB	Share
TRP Phase 3 Clinical Trial Programme for TR987
29/01/25	PRICE SENSITIVE	599.56KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
18/10/24	PRICE SENSITIVE	1.52MB	Share
TRP Takeover Panel Media release & Independent Director changes
25/09/24	PRICE SENSITIVE	121.55KB	Share
TRP TOV: TRP - Panel Accepts Undertaking and Declines to Conduct
20/09/24	PRICE SENSITIVE	266.46KB	Share
TRP TOV: TRP - Panel Receives Application
29/08/24	PRICE SENSITIVE	186.01KB	Share
TRP Appendix 4E and Annual Report 30 June 2024
22/08/24	PRICE SENSITIVE	1.06MB	Share
TRP Tony Charara Co-founder appointed as CEO
08/08/24	PRICE SENSITIVE	130.26KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	1008.67KB	Share
TRP TGA approval granted for Tissue Repair TR Pro
25/07/24	PRICE SENSITIVE	155.42KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	439.31KB	Share
TRP Appendix 4D and Half Year Report to 31 December 2023
29/02/24	PRICE SENSITIVE	530.95KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24	PRICE SENSITIVE	433.41KB	Share
TRP Third US Patent granted for Tissue Repair Glucoprime
19/12/23	PRICE SENSITIVE	190.65KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
30/10/23	PRICE SENSITIVE	518.18KB	Share
TRP Appendix 4E and Annual Report 30 June 2023
31/08/23	PRICE SENSITIVE	1.26MB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	482.99KB	Share
TRP FDA clears TR-987 to progress to Phase 3
29/05/23	PRICE SENSITIVE	178KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	401.11KB	Share
TRP Bank Deposits At SVB Available Tuesday 14 March 2023 AEDT
13/03/23	PRICE SENSITIVE	134.31KB	Share
TRP Update on Cash Held with Silicon Valley Bank
13/03/23	PRICE SENSITIVE	178.72KB	Share
TRP Appendix 4D and Half Year Report to 31 December 2022
22/02/23	PRICE SENSITIVE	888.67KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23	PRICE SENSITIVE	362.94KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	347.29KB	Share
TRP TR Pro accepted for peer reviewed journal publication
12/10/22	PRICE SENSITIVE	213.25KB	Share
TRP FDA Response Clarifies Path to Phase 3 Trials
28/09/22	PRICE SENSITIVE	207.95KB	Share
TRP Second US Patent granted for Glucoprime
05/09/22	PRICE SENSITIVE	152.96KB	Share
TRP Appendix 4E and Annual Report 30 June 2022
31/08/22	PRICE SENSITIVE	1.63MB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	271.34KB	Share
TRP Lodgement of Type C Meeting Request with US FDA
01/07/22	PRICE SENSITIVE	166.23KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	281.8KB	Share
TRP Tissue Repair Announces USA Patent Approval
04/03/22	PRICE SENSITIVE	128.94KB	Share
TRP Appendix 4D and Half Year Report to 31 December 2021
25/02/22	PRICE SENSITIVE	613.7KB	Share
TRP Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	427.58KB	Share
TRP Tissue Repair Progresses TR-987 towards Phase III
23/11/21	PRICE SENSITIVE	131.76KB	Share
TRP Suspension from Official Quotation
28/09/18	PRICE SENSITIVE	70.08KB	Share
TRPAdmission to Official List
10/05/10	PRICE SENSITIVE	24.28KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 27.5¢		Change 0.000(0.00%)		Mkt cap ! $16.62M

Open	High	Low	Value	Volume
27.5¢	27.8¢	27.5¢	$19.74K	71.66K

Buyers (Bids)

No.	Vol.	Price($)
3	56915	27.0¢

Sellers (Offers)

Price($)	Vol.	No.
28.5¢	44814	2

View Market Depth

No.	Vol.	Price($)
3	56915	0.270
1	11320	0.265
4	79095	0.260
1	8755	0.255
1	10500	0.210

Price($)	Vol.	No.
0.285	44814	2
0.290	62000	1
0.295	64000	1
0.300	244000	2
0.320	9000	1

Last trade - 15.17pm 19/09/2025 (20 minute delay)


Last 28.0¢		Change 0.000 ( 1.82 %)
Open	High	Low	Volume
27.5¢	28.0¢	27.5¢	3335
Last updated 15.45pm 19/09/2025 ?

TRP (ASX) Chart

TISSUE REPAIR LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available